Rapid Treatment of PTSD With Accelerated Non-Invasive Brain Stimulation
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorFlorida State University
About this trial
This study will test the clinical efficacy of an accelerated TMS (accel-TMS) protocol that rapidly addresses PTSD symptoms with 1 week (25 sessions over 5 days) of condensed treatment.
Eligibility criteria
Qualifiers
Adults age 18 years to 65 years old.
Meets DSM-5 criteria for PTSD with a PCL-5 score > 33
No changes in psychotropic medication (if taking psychotropic medication) and/or changes in supportive psychotherapy for 1 month prior to initial visit; and clinically appropriate to maintain stable treatment regimen for duration of trial.
Clinically competent to give informed written consent and ability to understand study procedures and to comply with them for the entire length of the study
Disqualifiers
None
Trial design
Treatments tested in this trial
- Cool B70 AP Coil - Active (dl-PFC)
- Cool B70 AP Coil- Sham (dl-PFC)
- Cool D-B80 AP Coil - Active (dm-PFC)
- Cool D-B80 AP Coil - Sham (dm-PFC)
- Cool B70 Treatment Coil - Active Only
Treatment groups
132 Participants
are divided into 5 treatment groupsSponsors and collaborators
Florida State University
Lead sponsor
United States Department of Defense
Collaborator
Source ClinicalTrials.gov